Magnetic 3D bioprinting

Magnetic 3D bioprinting is a methodology that employs biocompatible magnetic nanoparticles to print cells into 3D structures or 3D cell cultures. In this process, cells are tagged with magnetic nanoparticles (nanoshuttle) that are used to render them magnetic.[1][2] Once magnetic, these cells can be rapidly printed into specific 3D patterns using external magnetic forces that mimic tissue structure and function.

General principle

There are several advantages to using magnetic 3D bioprinting over other 3D printing modalities such as extrusion, photolithography, and stereolithography. This includes the rapid bioprinting process (15 min – 1 h) compared to the days-long processes of others;[3][4] the endogenous synthesis of extracellular matrix (ECM) without the need of an artificial protein substrate; and fine spatial control.[5][6][7] Using this system, 3D cell culture models can be rapidly printed, from simple spheroids and rings, to more complex organotypic models, like of the lung,[5] aortic valve,[6] and fat.[7]

History

The first commercially available 3D bioprinting system is being commercialized by Nano3D Biosciences, Inc. The first application of this system is for high-throughput and high-content drug screening.[8]

Process

The cells first need to be incubated in the presence of magnetic nanoparticles to make them more susceptible to manipulation through magnetic fields. The system developed by Nano3D Biosciences uses a "nanoshuttle" which is a nanoparticle assembly consisting of gold, magnetic iron oxide, and poly-L-lysine which assists in adhesion to the cell membrane via electrostatic interactions.[5] In this system, cells are magnetically printed into 3D patterns (rings or dots) using fields generated by permanent magnets. The cells within the printed construct interact with surrounding cells and the ECM to migrate, proliferate, and ultimately shrink the structure, typically within 24 hours.

When used as a toxicity assay, this shrinkage varies with drug concentration and is a label-free metric of cell function that can be easily captured and measured with brightfield imaging.[8] In the system developed by Nano3D Biosciences, the size of the pattern can be captured using an iPod-based system, which is programmed using a freely available app (Experimental Assistant) to image whole plates of up to 96 structures at small intervals (as small as 1 s) to efficiently capture pharmacodynamics. Results employing magnetic 3D bioprinting were recently published in Scientific Reports in October 2013.[8]

Application

Magnetic 3D bioprinting can be used to screen for cardiovascular toxicity, which accounts for 30% of drug withdrawals [9] Vascular smooth muscle cells are magnetically printed into 3D rings to mimic blood vessels that can contract and dilate. This system could potentially replace experiments using ex vivo tissue, which are costly and yield few data per experiment. Furthermore, magnetic 3D bioprinting can use human cells to approximate a human in vivo response better than with an animal model. This has been demonstrated by the bioassay which combines the benefits of 3D bioprinting in building tissue-like structures for study with the speed of magnetic printing.

Users

The target users for magnetic 3D bioprinting are in the pharmaceutical and CRO industries, where this system can be integrated early in the drug discovery process as a compound screen for toxicity and efficacy. In the future, magnetic 3D bioprinting could be applied to the field of regenerative medicine and organogenesis. Overall, magnetic 3D bioprinting is an effective tool to create faithful models of native tissue.

See also

References

  1. ↑ Souza, G. R. et al "Three-dimensional tissue culture based on magnetic cell levitation". Nat. Nanotechnol. 5, 291–6 (2010)
  2. ↑ Haisler, W. L. et al. "Three-dimensional cell culturing by magnetic levitation". Nat. Protoc. 8, 1940–9 (2013)
  3. ↑ Friedrich, J., Seidel, C., Ebner, R. & Kunz-Schughart, L. A. "Spheroid-based drug screen: considerations and practical approach". Nat. Protoc. 4, 309–24 (2009)
  4. ↑ Seiler, A. E. M. & Spielmann, H. "The validated embryonic stem cell test to predict embryotoxicity in vitro". Nat. Protoc. 6, 961–78 (2011)
  5. 1 2 3 Tseng, H. et al."Assembly of a three-dimensional multitype bronchiole coculture model using magnetic levitation". Tissue Eng. Part C. Methods 19, 665–75 (2013)
  6. 1 2 Tseng, H. et al. "A three-dimensional co-culture model of the aortic valve using magnetic levitation". Acta Biomater. 10, 173–82 (2014)
  7. 1 2 Daquinag, A. C., Souza, G. R. & Kolonin, M. G, "Adipose tissue engineering in three-dimensional levitation tissue culture system based on magnetic nanoparticles". Tissue Eng. Part C. Methods 19, 336–44 (2013)
  8. 1 2 3 Timm, D. M. et al. "A high-throughput three-dimensional cell migration assay for toxicity screening with mobile device-based macroscopic image analysis". Sci. Rep. 3, 3000 (2013)
  9. ↑ Gwathmey, J. K., Tsaioun, K. & Hajjar, R. J. "Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates". Expert Opin. Drug Metab. Toxicol. 5, 647–60 (2009)
  • Tran, Jasper (2015). "To Bioprint or Not to Bioprint". North Carolina Journal of Law and Technology. 17: 123–78. SSRN 2562952.
  • Tran, Jasper (2015). "Patenting Bioprinting". Harvard Journal of Law and Technology Digest. SSRN 2603693.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.